NSF awards $700,000 to support technology shown to pinpoint breast cancer tumors during surgery, improve outcomes
Summary
Vibronix Inc., which Cheng helped start while he was a professor at Purdue University, is developing AcouStar to make it easier for surgeons to pinpoint breast cancer tumors. (Photo by Jackie Ricciardi for Boston University Photography) Purdue startup receives funding aimed at reducing need for repeat surgeries WEST LAFAYETTE, Ind. – A Purdue University-affiliated company developing a surgical tool shown to pinpoint breast cancer tumors so they can be removed faster and more accurately and reduce the need for repeat surgeries in nearly a quarter of all lumpectomies has received a National Science Foundation grant for $703,352. Vibronix Inc. received a Small Business Innovation Research grant to advance the new technology called AcouStar. The advantage of wireless is that the energy source can be placed in the tumor the day before the surgery, making it less stressful on the medical team and the patient.